22Indexed trials
mesh condition
Dyskinesias
Intelligence
Dyskinesias intelligence: 22 indexed trials, 2 recruiting studies, 20 sponsors across 20 countries.
2Recruiting
20Sponsors
20Countries
Leading sponsors
Addex Pharma S.A.20 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)20 recruiting
Adamas Pharmaceuticals, Inc.10 recruiting
Appello Pharmaceuticals, Inc.11 recruiting
Assiut University10 recruiting
Daiichi Sankyo10 recruiting
Duke University10 recruiting
EMD Serono10 recruiting
Loma Linda University10 recruiting
Massachusetts Eye and Ear Infirmary11 recruiting
NeuroSearch A/S10 recruiting
Novartis Pharmaceuticals10 recruiting
Geographic activity
United States18trials
Germany4trials
Spain3trials
France3trials
Italy2trials
Austria2trials
Canada2trials
Hungary2trials
Romania2trials
Israel1trials
Australia1trials
New Zealand1trials
Leading interventions
Dipraglurant2trials
ACR3251trials
Amantadine1trials
AFQ0561trials
AP-4721trials
All investigations; laboratory and radiological, needed for diagnosis1trials
ADS-51021trials
Bilateral Deep Brain Stimulation1trials
CADD-Legacy® 1400 ambulatory infusion pump1trials
Cannabidiol1trials
Cerebellothalamic optimized deep brain stimulation1trials
ACP-1031trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.